However, since our study identified several other tissues including visceral adipose, EBV-transformed lymphocytes, and whole blood that had PIPs of 0.949 when fine-mapping eQTLs for TNFSF10; we suggest further research is warranted to explore the effects of TNFSF10 expression on ER- BC risk in these additional tissues. This evidence concerns the gene TNFSF10 and breast cancer.